Accelerating clinical research by enabling universal access to patients & providers, anywhere.
Decentralized Clinical Trials β’ Mobile Nursing β’ eCOA β’ eConsent β’ ePRO
501 - 1000
π° $200M Post-IPO Equity on 2021-10